Development of Animal Models for Lens and Corneal Diseases Using N-Methyl-N-Nitrosourea

Abstract

Insights

N-methyl-N-nitrosourea (MNU) induces apoptosis in ocular cells, creating animal models for cataract and corneal decompensation. These models are valuable for developing new therapies for these eye conditions.

Area of Science:

  • Ophthalmology
  • Toxicology
  • Cell Biology

Background:

  • N-methyl-N-nitrosourea (MNU) is a potent mutagenic alkylating toxicant.
  • Ocular diseases like cataracts and corneal decompensation significantly impact vision.
  • Developing reliable animal models is crucial for understanding disease mechanisms and testing therapies.

Purpose of the Study:

  • To induce apoptosis in lens epithelial cells (LECs) and corneal endothelial cells (CECs) using MNU.
  • To establish animal models for MNU-induced cataract and corneal endothelial decompensation.
  • To evaluate the dose and time dependency of MNU's ocular toxicity.

Main Methods:

  • Neonatal rats received intraperitoneal MNU injections; adult rabbits received intracameral MNU injections.
  • Functional and morphological analyses were performed at various time points post-treatment.
  • Techniques included Pentacam examination, TUNEL staining, and immunohistochemistry for 8-OHdG.

Main Results:

  • MNU treatment led to dose- and time-dependent apoptosis of LECs and CECs.
  • Neonatal rats developed mature cataracts, with histological evidence of lens fiber damage.
  • Rabbits showed corneal edema, increased corneal thickness, and significant ablation of CECs, with elevated 8-OHdG expression.

Conclusions:

  • MNU effectively induces ocular cell apoptosis in established animal models.
  • These MNU-induced models of cataract and corneal decompensation are valuable for therapeutic development.
  • Further research using these models can advance treatments for vision-impairing ocular conditions.